23andMe
Jump to navigation
Jump to search
A 23andMe is a biotechnology company that provides a direct-to-consumer genetic testing service based in Sunnyvale, California.
- Context:
- Example(s):
- …
- Counter-Example(s):
- See: DNA, Time (Magazine), Public Company, Linda Avey, Anne Wojcicki, Sunnyvale, California, Esther Dyson, Biotechnology, Genetic Genealogy, Direct-to-Consumer Advertising, Human Genome#Personal Genomes, Mobile Application, Genetic Testing.
References
2022
- (Wikipedia, 2022) ⇒ https://en.wikipedia.org/wiki/23andMe Retrieved:2022-3-16.
- 23andMe, Inc. is a publicly held personal genomics and biotechnology company based in Sunnyvale, California. It is best known for providing a direct-to-consumer genetic testing service in which customers provide a saliva sample that is laboratory analysed, using single nucleotide polymorphism genotyping,[1] to generate reports relating to the customer's ancestry and genetic predispositions to health-related topics. The company's name is derived from the 23 pairs of chromosomes in a wildtype human cell.[2]
The company had a previously fraught relationship with the United States Food and Drug Administration (FDA) due to its genetic health tests, but as of October 2015, DNA tests ordered in the US include a revised health component, per FDA approval.[3] [4] 23andMe has been selling a product with both ancestry and health-related components in Canada since October 2014,[5] [6] [7] and in the UK since December 2014.[8]
In 2007, 23andMe became the first company to begin offering autosomal DNA testing for ancestry, which all other major companies now use. Its saliva-based direct-to-consumer genetic testing business was named "Invention of the Year" by Time magazine in 2008.[9]
- 23andMe, Inc. is a publicly held personal genomics and biotechnology company based in Sunnyvale, California. It is best known for providing a direct-to-consumer genetic testing service in which customers provide a saliva sample that is laboratory analysed, using single nucleotide polymorphism genotyping,[1] to generate reports relating to the customer's ancestry and genetic predispositions to health-related topics. The company's name is derived from the 23 pairs of chromosomes in a wildtype human cell.[2]
- ↑ Goetz, Thomas (November 17, 2007). "23AndMe Will Decode Your DNA for $1,000. Welcome to the Age of Genomics". Wired. Archived from the original on March 12, 2014. Retrieved April 5, 2012.
- ↑ "Fact Sheet". 23andMe. Archived from the original on January 19, 2013. Retrieved November 27, 2013.
- ↑ Herper, Matthew (December 5, 2013). "23andMe Stops Offering Genetic Tests Related to Health". Forbes. Archived from the original on February 9, 2014. Retrieved December 6, 2013.
- ↑ Pollack, Andrew (October 21, 2015). "23andMe Will Resume Giving Users Health Data". The New York Times. ISSN 0362-4331. Archived from the original on March 4, 2016. Retrieved October 21, 2015.
- ↑ Ubelacker, Sheryl (October 1, 2014). "U.S. company launches genetic health and ancestry info service in Canada". Winnipeg Free Press. The Canadian Press. Retrieved October 7, 2014.
- ↑ Hansen, Darah (October 2, 2014). "5Q: Anne Wojcicki, CEO 23andMe on knowing your DNA data (and being married to the boss of Google)". Yahoo Finance Canada. Retrieved October 7, 2014.
- ↑ "23andme genetic testing service raises ethical questions". CBC News. October 2, 2014. Retrieved October 7, 2014.
- ↑ Roberts, Michelle; Rincon, Paul (December 2, 2014). "Controversial DNA test comes to UK". BBC News. Retrieved December 2, 2014.
- ↑ Hamilton, Anita (October 29, 2008). "Best Inventions of 2008". Time. Archived from the original on November 2, 2008. Retrieved April 5, 2012.
2022
- (LinkedIn, 2022) ⇒ https://linkedin.com/company/23andme/about/
- QUOTE: ... 23andMe, headquartered in Sunnyvale, CA, is a leading consumer genetics and research company. Founded in 2006, the company’s mission is to help people access, understand, and benefit from the human genome. 23andMe has pioneered direct access to genetic information as the only company with multiple FDA authorizations for genetic health risk reports. The company has created the world’s largest crowdsourced platform for genetic research, with 80 percent of its customers electing to participate. The 23andMe research platform has generated more than 180 publications on the genetic underpinnings of a wide range of diseases, conditions, and traits. The platform also powers the 23andMe Therapeutics group, currently pursuing drug discovery programs rooted in human genetics across a spectrum of disease areas, including oncology, respiratory, and cardiovascular diseases, in addition to other therapeutic areas. ...